Condylox (Actavis Pharma, Inc.)


Welcome to the PulseAid listing for the Condylox drug offered from Actavis Pharma, Inc.. This Decreased Mitosis [PE] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view the details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Actavis Pharma, Inc.
NON-PROPRIETARY NAME: podofilox
SUBSTANCE NAME: PODOFILOX
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Decreased Mitosis [PE]
ROUTE: TOPICAL
DOSAGE FORM: GEL
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 1997-03-13
END MARKETING DATE: 0000-00-00


Condylox HUMAN PRESCRIPTION DRUG Details:

Item DescriptionCondylox from Actavis Pharma, Inc.
LABELER NAME: Actavis Pharma, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 5(mg/g)
START MARKETING DATE: 1997-03-13
END MARKETING DATE: 0000-00-00
PRODUCT ID: 52544-045_6352d35d-98cf-4674-9810-b9e485f25ef0
PRODUCT NDC: 52544-045
APPLICATION NUMBER: NDA020529

Other PODOFILOX Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Actavis Pharma, Inc.Condylox
Paddock Laboratories, LLCPODOFILOX
Physicians Total Care, Inc.Podofilox